Annual Total Debt
$70.84 B
+$35.99 B+103.23%
31 December 2023
Summary:
Pfizer annual total debt is currently $70.84 billion, with the most recent change of +$35.99 billion (+103.23%) on 31 December 2023. During the last 3 years, it has risen by +$32.57 billion (+85.10%). PFE annual total debt is now at all-time high.PFE Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Debt
$66.62 B
-$2.06 B-3.00%
30 September 2024
Summary:
Pfizer quarterly total debt is currently $66.62 billion, with the most recent change of -$2.06 billion (-3.00%) on 30 September 2024. Over the past year, it has increased by +$3.02 billion (+4.75%). PFE quarterly total debt is now -5.97% below its all-time high of $70.84 billion, reached on 31 December 2023.PFE Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PFE Total Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +103.2% | +4.8% |
| 3 y3 years | +85.1% | +73.5% |
| 5 y5 years | +69.7% | +26.5% |
PFE Total Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +103.2% | -6.0% | +91.1% |
| 5 y | 5 years | at high | +103.2% | -6.0% | +91.1% |
| alltime | all time | at high | >+9999.0% | -6.0% |
Pfizer Total Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $66.62 B(-3.0%) |
| June 2024 | - | $68.68 B(-0.0%) |
| Mar 2024 | - | $68.71 B(-3.0%) |
| Dec 2023 | $70.84 B(+103.2%) | $70.84 B(+11.4%) |
| Sept 2023 | - | $63.60 B(-2.7%) |
| June 2023 | - | $65.34 B(+87.1%) |
| Mar 2023 | - | $34.93 B(+0.2%) |
| Dec 2022 | $34.86 B(-5.8%) | $34.86 B(-2.3%) |
| Sept 2022 | - | $35.68 B(-8.8%) |
| June 2022 | - | $39.13 B(+11.6%) |
| Mar 2022 | - | $35.05 B(-5.3%) |
| Dec 2021 | $37.00 B(-3.3%) | $37.00 B(-3.7%) |
| Sept 2021 | - | $38.41 B(+1.8%) |
| June 2021 | - | $37.73 B(-1.2%) |
| Mar 2021 | - | $38.19 B(-0.2%) |
| Dec 2020 | $38.27 B(-24.7%) | $38.27 B(-37.8%) |
| Sept 2020 | - | $61.53 B(-3.3%) |
| June 2020 | - | $63.61 B(+21.7%) |
| Mar 2020 | - | $52.28 B(+2.8%) |
| Dec 2019 | $50.84 B(+21.8%) | $50.84 B(-3.4%) |
| Sept 2019 | - | $52.65 B(+12.8%) |
| June 2019 | - | $46.67 B(+3.4%) |
| Mar 2019 | - | $45.14 B(+8.1%) |
| Dec 2018 | $41.74 B(-2.0%) | $41.74 B(-13.8%) |
| Sept 2018 | - | $48.43 B(+19.5%) |
| June 2018 | - | $40.52 B(-0.8%) |
| Mar 2018 | - | $40.83 B(-4.2%) |
| Dec 2017 | $42.61 B(+3.8%) | $42.61 B(-3.1%) |
| Sept 2017 | - | $43.95 B(+0.6%) |
| June 2017 | - | $43.70 B(-0.7%) |
| Mar 2017 | - | $44.01 B(+7.2%) |
| Dec 2016 | $41.06 B(+5.6%) | $41.06 B(-6.8%) |
| Sept 2016 | - | $44.07 B(-0.3%) |
| June 2016 | - | $44.18 B(+12.2%) |
| Mar 2016 | - | $39.37 B(+1.2%) |
| Dec 2015 | $38.90 B(+6.0%) | $38.90 B(+0.0%) |
| Sept 2015 | - | $38.90 B(+10.7%) |
| June 2015 | - | $35.12 B(-2.2%) |
| Mar 2015 | - | $35.92 B(-2.1%) |
| Dec 2014 | $36.68 B(+0.5%) | $36.68 B(-1.0%) |
| Sept 2014 | - | $37.05 B(-2.0%) |
| June 2014 | - | $37.83 B(+2.3%) |
| Mar 2014 | - | $36.97 B(+1.3%) |
| Dec 2013 | $36.49 B(-2.6%) | $36.49 B(-0.2%) |
| Sept 2013 | - | $36.55 B(-0.5%) |
| June 2013 | - | $36.75 B(-9.0%) |
| Mar 2013 | - | $40.38 B(+7.8%) |
| Dec 2012 | $37.46 B(-3.8%) | $37.46 B(-3.6%) |
| Sept 2012 | - | $38.86 B(+0.7%) |
| June 2012 | - | $38.57 B(-1.3%) |
| Mar 2012 | - | $39.07 B(+0.3%) |
| Dec 2011 | $38.94 B(-11.6%) | $38.94 B(-5.1%) |
| Sept 2011 | - | $41.04 B(-1.6%) |
| June 2011 | - | $41.71 B(+0.7%) |
| Mar 2011 | - | $41.40 B(-6.0%) |
| Dec 2010 | $44.03 B(-9.5%) | $44.03 B(-0.3%) |
| Sept 2010 | - | $44.17 B(+2.1%) |
| June 2010 | - | $43.27 B(-6.0%) |
| Mar 2010 | - | $46.05 B(-5.4%) |
| Dec 2009 | $48.66 B(+181.6%) | $48.66 B(+5.3%) |
| Sept 2009 | - | $46.20 B(-0.7%) |
| June 2009 | - | $46.54 B(+31.3%) |
| Mar 2009 | - | $35.45 B(+105.1%) |
| Dec 2008 | $17.28 B(+31.5%) | $17.28 B(+5.7%) |
| Sept 2008 | - | $16.34 B(-2.1%) |
| June 2008 | - | $16.69 B(-2.1%) |
| Mar 2008 | - | $17.05 B(+29.8%) |
| Dec 2007 | $13.14 B(+64.6%) | $13.14 B(+51.3%) |
| Sept 2007 | - | $8.69 B(+5.8%) |
| June 2007 | - | $8.21 B(+10.8%) |
| Mar 2007 | - | $7.41 B(-7.2%) |
| Dec 2006 | $7.98 B(-55.5%) | $7.98 B(-1.1%) |
| Sept 2006 | - | $8.07 B(-12.6%) |
| June 2006 | - | $9.23 B(-20.2%) |
| Mar 2006 | - | $11.57 B(-35.5%) |
| Dec 2005 | $17.94 B(-3.3%) | $17.94 B(+47.7%) |
| Sept 2005 | - | $12.14 B(-5.0%) |
| June 2005 | - | $12.78 B(-35.6%) |
| Mar 2005 | - | $19.83 B(+6.9%) |
| Dec 2004 | $18.55 B | $18.55 B(-1.4%) |
| Sept 2004 | - | $18.81 B(-0.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2004 | - | $18.97 B(+6.4%) |
| Mar 2004 | - | $17.84 B(+22.4%) |
| Dec 2003 | $14.57 B(+23.4%) | $14.57 B(-8.0%) |
| Sept 2003 | - | $15.84 B(+6.1%) |
| June 2003 | - | $14.92 B(+15.0%) |
| Mar 2003 | - | $12.98 B(+9.9%) |
| Dec 2002 | $11.81 B(+33.1%) | $11.81 B(-14.5%) |
| Sept 2002 | - | $13.81 B(+20.7%) |
| June 2002 | - | $11.44 B(+10.8%) |
| Mar 2002 | - | $10.33 B(+16.4%) |
| Dec 2001 | $8.87 B(+63.9%) | $8.87 B(+5.0%) |
| Sept 2001 | - | $8.45 B(+20.6%) |
| June 2001 | - | $7.00 B(+19.7%) |
| Mar 2001 | - | $5.85 B(+8.1%) |
| Dec 2000 | $5.41 B(-23.5%) | $5.41 B(-24.7%) |
| Sept 2000 | - | $7.19 B(+5.6%) |
| June 2000 | - | $6.81 B(+60.6%) |
| Mar 2000 | - | $4.24 B(-40.0%) |
| Dec 1999 | $7.07 B(+117.2%) | $7.07 B(+17.7%) |
| Sept 1999 | - | $6.01 B(+9.9%) |
| June 1999 | - | $5.47 B(+13.4%) |
| Mar 1999 | - | $4.82 B(+48.1%) |
| Dec 1998 | $3.26 B(+9.4%) | $3.26 B(-16.0%) |
| Sept 1998 | - | $3.88 B(+17.3%) |
| June 1998 | - | $3.31 B(+1.9%) |
| Mar 1998 | - | $3.24 B(+9.0%) |
| Dec 1997 | $2.98 B(+1.8%) | $2.98 B(-16.9%) |
| Sept 1997 | - | $3.58 B(-3.5%) |
| June 1997 | - | $3.71 B(+11.9%) |
| Mar 1997 | - | $3.31 B(+13.4%) |
| Dec 1996 | $2.92 B(+1.9%) | $2.92 B(-21.2%) |
| Sept 1996 | - | $3.71 B(+18.6%) |
| June 1996 | - | $3.13 B(+7.0%) |
| Mar 1996 | - | $2.92 B(+1.9%) |
| Dec 1995 | $2.87 B(+1.6%) | $2.87 B(-15.7%) |
| Sept 1995 | - | $3.40 B(-7.2%) |
| June 1995 | - | $3.67 B(-1.5%) |
| Mar 1995 | - | $3.73 B(+31.9%) |
| Dec 1994 | $2.82 B(+61.4%) | $2.82 B(+18.5%) |
| Sept 1994 | - | $2.38 B(-1.0%) |
| June 1994 | - | $2.41 B(+15.3%) |
| Mar 1994 | - | $2.09 B(+19.4%) |
| Dec 1993 | $1.75 B(-4.1%) | $1.75 B(-37.4%) |
| Sept 1993 | - | $2.79 B(+2.1%) |
| June 1993 | - | $2.73 B(+13.3%) |
| Mar 1993 | - | $2.41 B(+32.4%) |
| Dec 1992 | $1.82 B(-12.7%) | $1.82 B(-2.2%) |
| Sept 1992 | - | $1.86 B(+13.9%) |
| June 1992 | - | $1.64 B(-12.6%) |
| Mar 1992 | - | $1.87 B(-10.3%) |
| Dec 1991 | $2.09 B(+23.3%) | $2.09 B(+14.9%) |
| Sept 1991 | - | $1.82 B(+5.9%) |
| June 1991 | - | $1.72 B(+19.3%) |
| Mar 1991 | - | $1.44 B(-15.0%) |
| Dec 1990 | $1.69 B(-1.4%) | $1.69 B(+16.9%) |
| Sept 1990 | - | $1.45 B(+14.0%) |
| June 1990 | - | $1.27 B(+7.7%) |
| Mar 1990 | - | $1.18 B(-31.3%) |
| Dec 1989 | $1.72 B(+43.7%) | $1.72 B(>+9900.0%) |
| Sept 1989 | - | $0.00(0.0%) |
| June 1989 | - | $0.00(0.0%) |
| Mar 1989 | - | $0.00(-100.0%) |
| Dec 1988 | $1.19 B(+23.9%) | $1.19 B(>+9900.0%) |
| Sept 1988 | - | $0.00(0.0%) |
| June 1988 | - | $0.00(0.0%) |
| Mar 1988 | - | $0.00(-100.0%) |
| Dec 1987 | $963.80 M(+73.1%) | $963.80 M(>+9900.0%) |
| Sept 1987 | - | $0.00(0.0%) |
| June 1987 | - | $0.00(0.0%) |
| Mar 1987 | - | $0.00(-100.0%) |
| Dec 1986 | $556.70 M(+9.3%) | $556.70 M(>+9900.0%) |
| Sept 1986 | - | $0.00(0.0%) |
| June 1986 | - | $0.00(0.0%) |
| Mar 1986 | - | $0.00(-100.0%) |
| Dec 1985 | $509.40 M(-20.1%) | $509.40 M(>+9900.0%) |
| Sept 1985 | - | $0.00(0.0%) |
| June 1985 | - | $0.00(0.0%) |
| Mar 1985 | - | $0.00(-100.0%) |
| Dec 1984 | $637.20 M | $637.20 M(>+9900.0%) |
| Sept 1984 | - | $0.00(0.0%) |
| June 1984 | - | $0.00(0.0%) |
| Mar 1984 | - | $0.00 |
FAQ
- What is Pfizer annual total debt?
- What is the all time high annual total debt for Pfizer?
- What is Pfizer annual total debt year-on-year change?
- What is Pfizer quarterly total debt?
- What is the all time high quarterly total debt for Pfizer?
- What is Pfizer quarterly total debt year-on-year change?
What is Pfizer annual total debt?
The current annual total debt of PFE is $70.84 B
What is the all time high annual total debt for Pfizer?
Pfizer all-time high annual total debt is $70.84 B
What is Pfizer annual total debt year-on-year change?
Over the past year, PFE annual total debt has changed by +$35.99 B (+103.23%)
What is Pfizer quarterly total debt?
The current quarterly total debt of PFE is $66.62 B
What is the all time high quarterly total debt for Pfizer?
Pfizer all-time high quarterly total debt is $70.84 B
What is Pfizer quarterly total debt year-on-year change?
Over the past year, PFE quarterly total debt has changed by +$3.02 B (+4.75%)